Former Cardinal Health Expert Joins CIS and Expands Pre-Commercialization Services
![Top Quote](/images/red-top-quote.gif)
Neil DeHenes, formerly of Cardinal Health, joins CIS as Senior Director, Pre-Commercialization Services. Mr. DeHenes will provide consulting services and strategy development for commercialization functions related to sales, marketing and contracting for products distributed in the US market.
- Philadelphia, PA-NJ (1888PressRelease) August 09, 2013 - Compliance Implementation Services (CIS), a leading life sciences consulting firm, today announced Neil DeHenes has joined the company as Senior Director, Pre-Commercialization Services. Mr. DeHenes will lead CIS' Pre-Commercialization Consulting Services, which provides strategy, analysis and compliance support for manufacturers evaluating holistic commercialization options for their product. Previously, Mr. DeHenes was National Director of Sales Management, Specialty Solutions, at Cardinal Health.
Mr. DeHenes spent 11 years with Cardinal Health in roles ranging from finance to acquisitions. Throughout his tenure, he supported specialty pharmaceutical and biotech product launch activities. For the last four years he managed a sales team that sold services for third-party logistics and specialty distribution. As Director of Sales, Mr. DeHenes was responsible for facilitating commercialization strategies for specialty drug launches and providing third-party logistical services for pharmaceutical and biotech manufacturers. He is a graduate of Indiana University's Kelley School of Business.
"Neil's significant commercialization expertise broadens our team of experts and enhances the services we bring to our emerging manufacturers clients. His proven leadership assists these companies in developing and executing their strategic and operational goals. It's a pleasure to welcome him to CIS," said Jim Collins, CIS Co-founder and Chief Financial Officer.
"I'm pleased to join CIS, who is recognized for their successful track record of client support in the life sciences industry. This is an exceptional opportunity for me, and I look forward to furthering CIS' work in the pre-commercialization arena by supporting our clients with their strategic, organizational and financial decisions," said DeHenes.
Mr. DeHenes will work with emerging and established manufacturers to provide consulting services and strategy development for commercialization functions related to sales, marketing and contracting for products distributed in the US market. He will work with other CIS practices and partners to advise clients on their pre-commercialization needs, including but not limited to state licensing, registration in pricing compendia databases, third-party logistics, channel strategy, HUB support, contracting strategy and account management.
About Compliance Implementation Services (CIS)
Compliance Implementation Services (CIS) is a consulting firm focused on helping life sciences clients proactively manage complex compliance requirements. We offer a broad portfolio of services and solutions that expand deep into the clinical, manufacturing and commercial disciplines and that align with our clients' strategic priorities and business operations. CIS continually provides leadership, global regulatory knowledge, industry experience and a problem-solving culture that responds to today's compliance and commercial challenges. For more information, visit www.cis-partners.com.
###
space
space